Skip to main content
GenEmbryomics Limited (XGEN)
GenEmbryomics will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.75
Shares Offered
1,095,000
Deal Size
$5.20M

GenEmbryomics Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year Ending
 Jun '24 Jun '23
Selling, General & Admin
1.670.38
Research & Development
0.20.15
Other Operating Expenses
-0.060
Operating Expenses
1.810.52
Operating Income
-1.81-0.52
Interest Expense / Income
0.18-
Pretax Income
-1.98-0.52
Net Income
-1.98-0.52
Free Cash Flow
-1.17-0.46
EBITDA
-1.81-0.52
EBIT
-1.81-0.52
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).